Evidence map›Paper›PMID 38251204›Full record

ArticleTropical medicine and infectious disease2023

Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges.

Palak Mahajan, Kathirvel Soundappan, Neeta Singla, Kedar Mehta, Amenla Nuken, Pruthu Thekkur, Divya Nair, Sampan Rattan, Chaturanand Thakur, Kuldeep Singh Sachdeva and 1 more

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Palak MahajanInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi 110016, India.ORCID 0000-0003-2016-3627
Kathirvel SoundappanDepartment of Community Medicine & School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Neeta SinglaNational Institute of TB & Respiratory Disease, New Delhi 110030, India.
Kedar MehtaDepartment of Community Medicine, Gujarat Medical Education & Search Society Medical College, Vadodara 390021, India.ORCID 0000-0003-4374-9495
Amenla NukenInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi 110016, India.
Pruthu ThekkurCentre for Operational Research, International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.ORCID 0000-0001-5257-5074
Divya NairCentre for Operational Research, International Union Against Tuberculosis and Lung Disease, 2 Rue Jean Lantier, 75001 Paris, France.ORCID 0000-0001-5497-2858
Sampan RattanInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi 110016, India.
Chaturanand ThakurInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi 110016, India.
Kuldeep Singh SachdevaInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi 110016, India.
Bharati KalotteeInternational Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi 110016, India.
International Union Against Tuberculosis and Lung Disease · FRGujarat Cancer Society · INLRS Institute of Tuberculosis and Respiratory Diseases · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis preventive treatment (TPT) is an important intervention in preventing infection and reducing TB incidence among household contacts (HHCs). A mixed-methods study was conducted to assess the "Test and Treat" model of TPT care cascade among HHCs aged ≥5 years of pulmonary tuberculosis (PTB) patients (bacteriologically/clinically confirmed) being provided TPT care under Project Axshya Plus implemented in Maharashtra (India). A quantitative phase cohort study based on record review and qualitative interviews to understand the challenges and solutions in the TPT care cascade were used. Of the total 4181 index patients, 14,172 HHCs were screened, of whom 36 (0.3%) HHCs were diagnosed with tuberculosis. Among 14,133 eligible HHCs, 10,777 (76.3%) underwent an IGRA test. Of them, 2468 (22.9%) tested positive for IGRA and were suggested for chest X-ray. Of the eligible 2353 HHCs, 2159 (91.7%) were started on TPT, of whom 1958 (90.6%) completed the treatment. The median time between treatment initiation of index PTB patient and (a) HHC screening was 31 days; (b) TPT initiation was 64 days. The challenges in and suggested solutions for improving the TPT care cascade linked to subthemes were tuberculosis infection testing, chest X-ray, human resources, awareness and engagement, accessibility to healthcare facilities, TPT drugs, follow-up, and assessment. A systematic monitoring and time-based evaluation of TPT cascade care delivery followed by prompt corrective actions/interventions could be a crucial strategy for its effective implementation and for the prevention of tuberculosis.

Indexed as

challengesclose contactsIGRA testingisoniazid preventive treatment (IPT)latent TB infectionoperational researchstructured operational research training initiative (SORT IT)

Identifiers

PMID38251204
PMCPMC10818418
OpenAlexW4390176291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.